Cleveland Clinic Department of Rheumatic and Immunologic Disease
Cleveland Clinic Medical Specialty Institute offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.
RA
John Tesser
Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogenesis
- 465 views
- March 15, 2024
- 4
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Red Eye in RA: What Is the Differential Diagnosis in General and in Association With RA? What Questions Should You Ask the Patient? Can You Help Without Involving an Ophthalmologist?
FEATURING
James Rosenbaum
- 21 views
- September 21, 2020
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? Is There a Need for Salvage Therapies with Rituximab, Tocilizumab, and IVIg? What Is the Best Treatment Approach?
FEATURING
Joseph Parambil
- 132 views
- September 18, 2020
- 1
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Connective Tissue Disease-Associated Interstitial Lung Disease: Why Is It Important to Distinguish CTD-ILD and Idiopathic Interstitial Pneumonia? Distribution and Histologic Patterns in CTD-ILD
FEATURING
Joseph Parambil
- 112 views
- September 18, 2020
- 1
Cleveland Clinic Rheumatology
bDMARDs and nbDMARDs in RA: Is VTE a Clinical Concern in RA?
FEATURING
Arthur Kavanaugh,
John J. Cush
- 7 views
- September 3, 2020
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in PsA? How Safe Is Filgotinib in RA Patients With IR? What Does the Data Suggest on Upadacitinib & Baricitinib?
FEATURING
Arthur Kavanaugh,
John J. Cush
- 26 views
- September 3, 2020
Cleveland Clinic Rheumatology
RA & 8 TNFi Biosimilars Efficacy Analysis: Can Multiple bDMARD Switches Impact Clinical Efficacy? Is There an Evidence That RA Mortality Gap is Closing With Improved CVD Outcomes and What is The Impact of Immunomodulating Agents on CVD Risk?
FEATURING
Arthur Kavanaugh,
John J. Cush
- 7 views
- September 3, 2020
Cleveland Clinic Rheumatology
Refractory Pain in Early RA: What Are the Alternative Treatment Strategies in These Patients?
FEATURING
Arthur Kavanaugh,
John J. Cush
- 7 views
- September 3, 2020
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Rheumatology – Oncology: Cases with the Masters
FEATURING
Leonard Calabrese,
Vamsidhar Velcheti
- 14 views
- August 28, 2020
Cleveland Clinic Rheumatology
Links Between Chronic Inflammation and Atherosclerotic Disease and Evidence-Based Studies Addressing Systemic Inflammation. What are Available Screening Techniques and Practical Approaches to Treat CV Comorbidities in These Patients?
FEATURING
Elaine Husni
- 546 views
- July 30, 2020
Cleveland Clinic Rheumatology
Human Behavior and Immunity – Slowing Aging?
FEATURING
Leonard Calabrese
- 2,114 views
- July 30, 2020
- 13
Cleveland Clinic Rheumatology
Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With Pre-existing Autoimmune Diseases? Do Biomarkers Exist to Help Predict irAEs? Will Immunosuppressive Medications, Previously Used for irAEs Treatment Blunt the Anti-Tumor Response?
FEATURING
Cassandra Calabrese
- 128 views
- July 30, 2020
- 1
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Immune Related Adverse Events from Cancer Immunotherapy: The Role of the Rheumatologist in Caring for Patients Who Develop Rheumatic and Dermatologic Immune Related Adverse Events (irAEs).
FEATURING
Cassandra Calabrese
- 111 views
- July 30, 2020
Cleveland Clinic Rheumatology
Cases with the Masters: Clinical Challenges in Rheumatoid Arthritis
FEATURING
Leonard Calabrese,
Edward Keystone,
Arthur Kavanaugh,
Iain Mcinnes,
Jonathan Kay,
John J. Cush
- 59 views
- January 23, 2019
Cleveland Clinic Rheumatology
Targeting the IL1 Family in Autoimmune and Autoinflammatory Diseases
FEATURING
John Looney
- 452 views
- July 30, 2020
- 2
Cleveland Clinic Medical Specialty Institute
Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective
FEATURING
Arthur Kavanaugh,
John J. Cush
- 75 views
- January 10, 2019
Cleveland Clinic Rheumatology
Predicting Outcomes in RA - The Role of Biomarkers
FEATURING
Jonathan Kay
- 38 views
- January 12, 2019
Cleveland Clinic Rheumatology
Pre-Rheumatoid Arthritis: Can We Define It and Prevent Its Progression?
FEATURING
Michael Holers
- 81 views
- January 14, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Cytokine Profiles in Health and Disease
FEATURING
Iain Mcinnes
- 13 views
- January 14, 2019
Cleveland Clinic Rheumatology
Increased Inflammation and Disease Activity Among Current Cigarette Smokers with RA
FEATURING
Ted Mikuls
- 16 views
- January 15, 2019
Cleveland Clinic Rheumatology
Advances in Rheumatoid Arthritis
FEATURING
William Rigby
- 424 views
- January 15, 2019
- 4
Cleveland Clinic Rheumatology
PPACMAN Update (Rheumatology/Dermatology)
FEATURING
Joseph Merola
- 52 views
- January 15, 2019
Cleveland Clinic Rheumatology
Preventing Infections in Patients Treated with Biologics
FEATURING
Cassandra Calabrese
- 515 views
- January 15, 2019
- 3
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Revisiting Anti-TNF 20 Years Later
FEATURING
John Looney
- 88 views
- January 15, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
T-Cell and B-Cell (and Other) Targeting in IMIDs
FEATURING
Gregg Silverman
- 41 views
- January 15, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
IL6 Targeting
FEATURING
Leonard Calabrese
- 44 views
- January 15, 2019
Cleveland Clinic Rheumatology
Tailoring Therapy Based on Disease Duration: Is There A Window of Opportunity?
FEATURING
Edward Keystone
- 23 views
- January 15, 2019
Cleveland Clinic Rheumatology
Predicting the Outcome of Treatment De-Escalation or Discontinuation: What Do We Know?
FEATURING
Arthur Kavanaugh
- 214 views
- January 16, 2019
- 2
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Why Personal Behavior Affects Immune Mediated Inflammatory Diseases
FEATURING
Leonard Calabrese
- 241 views
- January 23, 2019
- 1
Cleveland Clinic Rheumatology
Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizumab Pegol
FEATURING
Leonard Calabrese,
Meghna Jani
- 71 views
- January 18, 2019